Newlands A[au] - Search Results

Year	Number of Results
1996	1
1997	1
2014	3
2015	3
2016	1
2017	1
2023	1

1

Inhibition of capsaicin-driven nasal hyper-reactivity by SB-705498, a TRPV1 antagonist.

Holland C, van Drunen C, Denyer J, Smart K, Segboer C, Terreehorst I, Newlands A, Beerahee M, Fokkens W, Tsitoura DC. Holland C, et al. Among authors: newlands a. Br J Clin Pharmacol. 2014 May;77(5):777-88. doi: 10.1111/bcp.12219. Br J Clin Pharmacol. 2014. PMID: 23909699 Free PMC article. Clinical Trial.

2

Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial.

Khalid S, Murdoch R, Newlands A, Smart K, Kelsall A, Holt K, Dockry R, Woodcock A, Smith JA. Khalid S, et al. Among authors: newlands a. J Allergy Clin Immunol. 2014 Jul;134(1):56-62. doi: 10.1016/j.jaci.2014.01.038. Epub 2014 Mar 22. J Allergy Clin Immunol. 2014. PMID: 24666696 Clinical Trial.

3

Putative active site template model for cytochrome P4502C9 (tolbutamide hydroxylase).

Jones BC, Hawksworth G, Horne VA, Newlands A, Morsman J, Tute MS, Smith DA. Jones BC, et al. Among authors: newlands a. Drug Metab Dispos. 1996 Feb;24(2):260-6. Drug Metab Dispos. 1996. PMID: 8742240

4

TRPV1 inhibition does not prevent cold dry air-elicited symptoms in non-allergic rhinitis.

Murdoch RD, Bareille P, Denyer J, Newlands A, Bentley J, Smart K, Yarnall K, Patel D. Murdoch RD, et al. Among authors: newlands a. Int J Clin Pharmacol Ther. 2014 Apr;52(4):267-76. doi: 10.5414/CP202013. Int J Clin Pharmacol Ther. 2014. PMID: 24472402 Clinical Trial.

5

Anticipatory guidance to prevent infant sleep problems within a randomised controlled trial: infant, maternal and partner outcomes at 6 months of age.

Galland BC, Sayers RM, Cameron SL, Gray AR, Heath AM, Lawrence JA, Newlands A, Taylor BJ, Taylor RW. Galland BC, et al. Among authors: newlands a. BMJ Open. 2017 Jun 2;7(5):e014908. doi: 10.1136/bmjopen-2016-014908. BMJ Open. 2017. PMID: 28576897 Free PMC article. Clinical Trial.

6

Efficacy and safety of fluticasone furoate/vilanterol (50/25 mcg; 100/25 mcg; 200/25 mcg) in Asian patients with chronic obstructive pulmonary disease: a randomized placebo-controlled trial.

Zheng J, de Guia T, Wang-Jairaj J, Newlands AH, Wang C, Crim C, Zhong N. Zheng J, et al. Among authors: newlands ah. Curr Med Res Opin. 2015 Jun;31(6):1191-200. doi: 10.1185/03007995.2015.1036016. Curr Med Res Opin. 2015. PMID: 25830381 Clinical Trial.

7

Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial.

Kalberg C, O'Dell D, Galkin D, Newlands A, Fahy WA. Kalberg C, et al. Among authors: newlands a. Drugs R D. 2016 Jun;16(2):217-27. doi: 10.1007/s40268-016-0131-2. Drugs R D. 2016. PMID: 27028749 Free PMC article. Clinical Trial.

8

Lactation Consultant Support from Late Pregnancy with an Educational Intervention at 4 Months of Age Delays the Introduction of Complementary Foods in a Randomized Controlled Trial.

Cameron SL, Heath AL, Gray AR, Churcher B, Davies RS, Newlands A, Galland BC, Sayers RM, Lawrence JA, Taylor BJ, Taylor RW. Cameron SL, et al. Among authors: newlands a. J Nutr. 2015 Jul;145(7):1481-90. doi: 10.3945/jn.114.202689. Epub 2015 May 20. J Nutr. 2015. PMID: 25995280 Clinical Trial.

9

Efficacy and safety of once-daily inhaled umeclidinium/vilanterol in Asian patients with COPD: results from a randomized, placebo-controlled study.

Zheng J, Zhong N, Newlands A, Church A, Goh AH. Zheng J, et al. Among authors: newlands a. Int J Chron Obstruct Pulmon Dis. 2015 Sep 2;10:1753-67. doi: 10.2147/COPD.S81053. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26366068 Free PMC article. Clinical Trial.

10

Efficacy and safety of GSK3772847 in participants with moderate-to-severe asthma with allergic fungal airway disease: A phase IIa randomized, multicenter, double-blind, sponsor-open, comparative trial.

Akinseye C, Crim C, Newlands A, Fairman D. Akinseye C, et al. Among authors: newlands a. PLoS One. 2023 Feb 3;18(2):e0281205. doi: 10.1371/journal.pone.0281205. eCollection 2023. PLoS One. 2023. PMID: 36735745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results